Heron Therapeutics (HRTX) Revenue (2010 - 2026)
Heron Therapeutics' (HRTX) quarterly Revenue came in at $34.7 million in Q1 2026, down 10.78% YoY from $38.9 million in Q1 2025, and down 14.48% on a QoQ basis from $40.6 million in Q4 2025.
Heron Therapeutics (HRTX) Revenue (2010 - 2026) Analysis & Trends
Heron Therapeutics (HRTX) has 12 years of Revenue data on file, last reported at $34.7 million in Q1 2026.
- Quarterly Revenue fell 10.78% year-over-year to $34.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $150.7 million (up 1.48% YoY) and the FY2025 annual result came in at $154.9 million, up 7.36% from the prior year.
- Revenue fell to $34.7 million in Q1 2026, from $40.6 million in the prior quarter.
- In the past five years, Revenue ranged from a high of $40.8 million in Q4 2024 to a low of $23.5 million in Q1 2022.
- A 5-year average of $33.4 million and a median of $34.2 million in 2023 frame the typical range for Revenue.
- Annual changes were most pronounced in 2022 — Revenue surged 45.38% — and 2026, when it fell 10.78%.
- Tracing HRTX's Revenue over 5 years: stood at $30.0 million in 2022, then rose by 14.0% to $34.2 million in 2023, then rose by 19.13% to $40.8 million in 2024, then fell by 0.47% to $40.6 million in 2025, then retreated by 14.48% to $34.7 million in 2026.
- The last three Revenue figures came in at $34.7 million (Q1 2026), $40.6 million (Q4 2025), and $38.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 145.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1.71 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.29 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.06 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 425.49 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 674.14 Mn |
| 10 | Heron Therapeutics | 59.96 Mn | 17.29 Mn | 26.09 Mn | 37.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 37.67 Mn |
| Mar 31, 2026 | 34.71 Mn |
| Dec 31, 2025 | 40.59 Mn |
| Sep 30, 2025 | 38.21 Mn |
| Jun 30, 2025 | 37.20 Mn |
| Mar 31, 2025 | 38.90 Mn |
| Dec 31, 2024 | 40.78 Mn |
| Sep 30, 2024 | 32.81 Mn |
| Jun 30, 2024 | 36.02 Mn |
| Mar 31, 2024 | 34.67 Mn |
| Dec 31, 2023 | 34.23 Mn |
| Sep 30, 2023 | 31.43 Mn |
| Jun 30, 2023 | 31.76 Mn |
| Mar 31, 2023 | 29.62 Mn |
| Dec 31, 2022 | 30.03 Mn |
| Sep 30, 2022 | 26.56 Mn |
| Jun 30, 2022 | 27.63 Mn |
| Mar 31, 2022 | 23.46 Mn |
| Dec 31, 2021 | 20.66 Mn |
| Sep 30, 2021 | 23.23 Mn |